HomeCompareFFF vs MRK

FFF vs MRK: Dividend Comparison 2026

FFF yields 9.70% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $19.7K in total portfolio value· pulled ahead in Year 7
10 years
FFF
FFF
● Live price
9.70%
Share price
$20.62
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38.0K
Annual income
$1,785.36
Full FFF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — FFF vs MRK

📍 MRK pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FFF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FFF
Annual income on $10K today (after 15% tax)
$824.44/yr
After 10yr DRIP, annual income (after tax)
$1,517.56/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $7,079.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FFF + MRK for your $10,000?

FFF: 50%MRK: 50%
100% MRK50/50100% FFF
Portfolio after 10yr
$47.9K
Annual income
$5,949.57/yr
Blended yield
12.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FFF
No analyst data
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FFF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFFFMRK
Forward yield9.70%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$38.0K$57.7K
Annual income after 10y$1,785.36$10,113.78
Total dividends collected$13.8K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FFF vs MRK ($10,000, DRIP)

YearFFF PortfolioFFF Income/yrMRK PortfolioMRK Income/yrGap
1$11,670$969.93$11,213$373.04+$457.00FFF
2$13,545$1,057.85$12,667$512.06+$878.00FFF
3$15,640$1,147.47$14,439$708.14+$1.2KFFF
4$17,973$1,238.32$16,640$988.16+$1.3KFFF
5$20,562$1,329.96$19,432$1,394.07+$1.1KFFF
6$23,423$1,421.93$23,057$1,992.90+$366.00FFF
7← crossover$26,576$1,513.83$27,889$2,894.79$1.3KMRK
8$30,042$1,605.27$34,518$4,286.29$4.5KMRK
9$33,841$1,695.89$43,912$6,494.35$10.1KMRK
10$37,995$1,785.36$57,714$10,113.78$19.7KMRK

FFF vs MRK: Complete Analysis 2026

FFFStock

FFF is designed for investors with a long-term time horizon by targeting founder-led companies. The fund seeks capital appreciation, believing these companies offer superior risk-adjusted returns. The fund defines founder-led companies to be managed by a founder serving as a Chief Officer (CEO, CTO, CSO or CMO). Using a proprietary, rules-based process, it selects 100 of the largest 200 founder-led firms using market-cap and other fundamental factors. It considers market highs and lows to navigate market cycles and remove emotional decision making. Except for technology, FFF does not intend to concentrate in any single sector and may invest in firms of any size. The fund may invest in non-US companies, provided they are listed on a US exchange. The market cap-weighted portfolio limits single security exposure to 7.5%. The actively managed portfolio is rebalanced and reconstituted quarterly.

Full FFF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FFF vs SCHDFFF vs JEPIFFF vs OFFF vs KOFFF vs MAINFFF vs JNJFFF vs ABBVFFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.